BIT
CLCD

BlackRock Institutional Trust’s CoLucid Pharmaceuticals, Inc. CLCD Stock Holding History

BlackRock Institutional Trust’s Portfolio CLCD Stock Details CLCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$6.25M Buy
171,700
+82,007
+91% +$2.9M ﹤0.01% 2640
2016
Q3 		$3.42M Buy
+89,693
New +$1.33M ﹤0.01% 2842

Other funds holding CLCD

NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

BlackRock Institutional Trust's CLCD Position: Q4 2016 in Review

BlackRock Institutional Trust increased its CoLucid Pharmaceuticals, Inc. (CLCD) stake by 91% in Q4 2016, buying an estimated $2.9M and bringing the position to 171,700 shares worth $6.25M. The position accounts for ﹤0.01% of the portfolio, ranked #2640.

BlackRock Institutional Trust first reported a position in CLCD in Q3 2016 and has held it in 2 quarters since. 76 funds tracked by Wall St. Rank hold CLCD as of Q4 2016.

  • BlackRock Institutional Trust held 171,700 shares of CoLucid Pharmaceuticals, Inc. worth $6.25M as of Q4 2016.
  • BlackRock Institutional Trust bought 82,007 CoLucid Pharmaceuticals, Inc. shares in Q4 2016, an estimated $2.9M.
  • CoLucid Pharmaceuticals, Inc. made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #2640 holding.
  • BlackRock Institutional Trust first reported a position in CoLucid Pharmaceuticals, Inc. in Q3 2016 and has held it in 2 quarters since.
  • 76 funds tracked by Wall St. Rank held CoLucid Pharmaceuticals, Inc. as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.